Panasonic Unveils CardioHealth Station in Europe

By Panasonic Healthcare Co. Ltd., PRNE
Tuesday, November 16, 2010

DUSSELDORF, Germany, November 17, 2010 - Panasonic announced today the European unveiling of its new innovative
tool for personalized preventive medicine, the CardioHealth Station, at
renowned medical trade fair MEDICA in Dusseldorf, Germany (Hall 9, booth
E47). The device is designed to assist medical professionals in making a
quick and valuable assessment of cardiovascular health. The CardioHealth
Station will be available in Europe by spring 2011 after obtaining all
necessary regulatory approvals.

Recently published studies (ARIC & MESA)*1 have shown that valuable
information is revealed in the assessment of vascular health, and the risks
of a cardiovascular event associated with those assessments. The ARIC*2
study, a recent multi-institution study, reveals that certain patients can be
reclassified by looking at the carotid-intima media thickness and the
presence of plaque in the said patient. As a result, Panasonic developed
CardioHealth Station, a much needed device that will help the doctor, and in
some cases the technician, quickly detect thickened carotid arteries. The
carotid artery is the branch that goes from the heart up the neck, and
provides blood to the front of the face and the brain. What once used to be
difficult and impractical to do on a mass basis is now made possible by the
innovative automation technology loaded as standard in the CardioHealth

Professor Raimund Erbel, Department of Cardiology, West-German Heart
Center Essen, welcomes this novel development: "The ultrasound of carotid
arteries is critical because physicians, and in particular cardiologists,
agree that this leads to a more accurate assessment of patient risk than
looking at risk factors alone."

The CardioHealth Station has a built-in portable ultrasound system
optimized to perform a non-invasive examination of the peripheral vessels. It
provides an automated measurement of the intima-media thickness (IMT) of
peripheral arteries such as the common carotids and allows the user to search
for arterial plaques using real-time B-mode imaging. The touchscreen keyboard
allows the user to input various parameters relating to traditional
cardiovascular risk factors. A built in calculator provides risk scores
commonly used in a variety of geographical locations (Framingham Risk Score,
PROCAM Health Check Score, Reynolds Risk Score, Risk score based on the SCORE
Project). This information is supplemented with an IMT measurement of the
artery to generate a comprehensive report to aid the physician in assessing
cardiovascular risk.

Chairman and CEO of Panasonic Europe Ltd. Laurent Abadie, stated, "We at
Panasonic see the CardioHealth Station as a step forward in personalized
preventive medicine. Not only will it enhance patient outcomes, but it has
the potential to reduce healthcare costs in Europe through early detection
and quicker diagnosis."

In May, the president of Panasonic Corporation, Fumio Ohtsubo
stated Panasonic's worldwide intention to reinforce the healthcare business
and he announced the plan to change its subsidiary's name from Panasonic
Shikoku Electronics Co.,Ltd to Panasonic Healthcare Co., Ltd on October 1,
. On October 25, Panasonic Corporation of North America announced the
formation of CardioNexus Corporation, which became the launching platform for
CardioHealth(R) Station in North America on November 14th. Panasonic is
currently applying for FDA and EMA approval of the CardioHealth(R) Station,
and expects sales to begin as soon as approval is received from the
appropriate regulatory authorities.

"Helping the world reduce global healthcare costs is in everybody's
interest," said Osamu Takahashi, the Director of Global Strategy at Panasonic
Healthcare Co., Ltd. "Panasonic believes the CardioHealth Station, a first in
a series of products - will help achieve the corporate goal of improving
society through the early detection of disease."

*1 Atherosclerosis Risk in Communities (ARIC) and the ongoing Multiethnic
Study of Atherosclerosis (MESA). Both studies are sponsored by the National
Heart Lung and Blood Institute. More information about the ARIC study can be
found at ; more information about the MESA
study can be found at

*2 ARIC study can be found at

For more company information, please visit

Ann Blumenstock, Red Door Communications, ablumenstock at, +44(0)20-8392-8040; Wilson Solano, Panasonic Europe Ltd., Wilson.Solano at,

will not be displayed